Trial intelligence / Profile preview

TDS-943 in osteoarthritis of the knee

NCT00546507Phase 3Completed

Sponsor
Mika Pharmaceuticals
Start
Oct 2007
Primary completion
Oct 2008
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of diclofenac in osteoarthritis (OA), sponsored by Mika Pharmaceuticals. Started Oct 2007; status: completed.

02

Drugs

diclofenac
03

Conditions

osteoarthritis (OA)

Beyond the preview

Go deeper on NCT00546507.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00546507.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call